Albumin loss
Showing 1 - 25 of >10,000
End Stage Renal Disease, Hemodiafiltration, Hemodialysis Trial in Cairo (BIOPURE 260HF dialyzer)
Completed
- End Stage Renal Disease
- +2 more
- BIOPURE 260HF dialyzer
-
Cairo, Governorate, EgyptAin Shams University Hospitals
Mar 11, 2022
Blood Loss, Surgical, Fluid Retention Trial in Bern (Hyperoncotic Albumin 20%, Isooncotic Albumin 5%, Ringer's Lactate
Recruiting
- Blood Loss, Surgical
- Fluid Retention
- Hyperoncotic Albumin 20%
- +2 more
-
Bern, BE, SwitzerlandPatrick Wuethrich, Department of Anaesthesiology and Pain Therap
May 25, 2022
Habitual Abortion, Recurrent Pregnancy Loss, Fertility Disorders Trial in Aalborg (Human Intravenous Immunoglobulins, (Privigen
Recruiting
- Habitual Abortion
- +3 more
- Human Intravenous Immunoglobulins, (Privigen (R), CLS Behring)
- +3 more
-
Aalborg, Denmark• The Centre for Recurrent Pregnancy Loss of Western Denmark, De
Jul 17, 2021
Adolescent Idiopathic Scoliosis Trial in Atlanta (Radioisotope I-131-labeled albumin)
Completed
- Adolescent Idiopathic Scoliosis
- Radioisotope I-131-labeled albumin
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta - Egleston Hospital
Jun 9, 2021
Blood Loss, Surgical, Fluid Retention Trial in Bern (albumin 20%)
Completed
- Blood Loss, Surgical
- Fluid Retention
- albumin 20%
-
Bern, BE, SwitzerlandPatrick Wuethrich, Department of Anaesthesiology and Pain Therap
Feb 18, 2020
Pancreas Disease Trial
Recruiting
- Pancreas Disease
-
Copenhagen, DenmarkRigshospitalet
Aug 31, 2022
Solid Tumor, Adult Trial (EOC202, albumin-bound paclitaxel)
Not yet recruiting
- Solid Tumor, Adult
- EOC202
- albumin-bound paclitaxel
- (no location specified)
Apr 7, 2022
Tooth Extraction Status Nos Trial (Study Group, Control Group)
Not yet recruiting
- Tooth Extraction Status Nos
- Study Group
- Control Group
- (no location specified)
Nov 24, 2023
End Stage Renal Disease Trial in Elsenfeld (THERANOVA 400 dialyzer prototype AA, THERANOVA 400 dialyzer prototype BB, FX CorDiax
Completed
- End Stage Renal Disease
- THERANOVA 400 dialyzer prototype AA
- +3 more
-
Elsenfeld, GermanyDialysexentrum Elsenfeld
Feb 17, 2022
Preoperative HALP and Immediate Postoperative Outcomes
Completed
- Hemoglobins
- +6 more
- pantients undergoing pancreaticoduodenectomy
-
Bharatpur, Bagmati, NepalChitwan Medical College Teaching Hospital
Aug 16, 2022
Breast Cancer Trial in Duarte, Pasadena (drug, other, procedure)
Active, not recruiting
- Breast Cancer
- paclitaxel albumin-stabilized nanoparticle formulation
- +6 more
-
Duarte, California
- +1 more
Jan 31, 2023
Obesity, Morbid Trial in Paris (Laparoscopic OAGB, Laparoscopic RYGB)
Not yet recruiting
- Obesity
- Morbid
- Laparoscopic OAGB
- Laparoscopic RYGB
-
Paris, FranceHôpital Bichat Claude-Bernard
Oct 2, 2023
NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)
Recruiting
- Non-small Cell Lung Cancer
- Nutritional intervention
- Immunotherapy
-
Rotterdam, NetherlandsErasmus MC
Jun 5, 2023
Serum Albumin and Total Protein in Survival of Cancer Cachectic
Not yet recruiting
- Cancer
- BMI
- (no location specified)
Oct 21, 2021
Diabetic Kidney Disease Trial in United States (TMX-049, Placebo)
Identify microRNAs in Cachexia in Pancreatic Carcinoma
Recruiting
- Resectable Pancreatic Adenocarcinoma
- Pancreatic cancer microRNA and messenger RNA expression.
-
Oklahoma City, OklahomaStephenson Cancer Center
Jan 9, 2023
Nutritional Status on Oncologic and Operative Outcome in
Recruiting
- Retroperitoneal Sarcoma
- +5 more
- Measurement of body composition with computed tomography (CT)
- +5 more
-
Ljubljana, SloveniaInstitute of Oncology Ljubljana
Dec 2, 2022
Nephrotic Syndrome Trial in Warsaw (Ketosteril, Medium Protein Diet (MPD))
Recruiting
- Nephrotic Syndrome
- Ketosteril
- Medium Protein Diet (MPD)
-
Warsaw, Masovian District, PolandDepartment of Internal Diseases, Nephrology and Dialysis, Milita
Jan 30, 2023
Type 2 Diabetes Trial in Beijing (GA guided anti-diabetic therapy adjustment, current guidelines to adjust treatment)
Recruiting
- Type 2 Diabetes Mellitus
- GA guided anti-diabetic therapy adjustment
- current guidelines to adjust treatment
-
Beijing, China
- +9 more
Jan 30, 2023
Coronary Artery Disease Trial in Ulsan (GENOSS® DCB, SeQuent® Please NEO)
Active, not recruiting
- Coronary Artery Disease
- GENOSS® DCB
- SeQuent® Please NEO
-
Ulsan, Korea, Republic ofUlsan University Hospital
Jan 29, 2023
Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)
Not yet recruiting
- Nephrotic Syndrome
- Dapagliflozin and Standard therapy (ACEI or ARB).
- Standard Therapy (ACEI or ARB).
- (no location specified)
Jul 26, 2023
Frailty Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Frailty
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 2, 2023
Age-Related Frailty Trial in Santa Monica (Therapeutic Plasma Exchange (TPE))
Enrolling by invitation
- Age-Related Frailty
- Therapeutic Plasma Exchange (TPE)
-
Santa Monica, CaliforniaNeurological Associates - The Interventional Group
Apr 11, 2022
Hyperhydration and Polyneuromyopathy in Critically Ill Patients
Completed
- Respiratory Distress Syndrome, Acute
- +6 more
- Bioelectrical impedance vector analysis (BIVA)
- +2 more
-
Ostrava, Czech Republic, CzechiaUniversity Hospital Ostrava
Aug 7, 2023
ICU Fluid Utilization Survey in Southeast Asia
Not yet recruiting
- Critical Illness
- 10-min online survey
- (no location specified)
Sep 6, 2023